Filing Details
- Accession Number:
- 0001012975-13-000434
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-06 17:10:35
- Reporting Period:
- 2013-09-04
- Filing Date:
- 2013-09-06
- Accepted Time:
- 2013-09-06 17:10:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1547100 | Liam Ratcliffe | C/O New Leaf Venture Partners 7 Times Square, Suite 3502 New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-09-04 | 236,116 | $5.87 | 3,140,070 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2013-09-05 | 201,598 | $5.77 | 2,938,472 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2013-09-06 | 139,572 | $5.68 | 2,798,900 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P. ("NLVA II"). Dr. Liam Ratcliffe ("Dr. Ratcliffe"), in his capacity as a limited partner of NLVA II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Ratcliffe disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.